Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • How Algorae is using AI and supercomputers to transform medicine
    • News

    How Algorae is using AI and supercomputers to transform medicine

    The conversations surrounding artificial intelligence (AI) and its scope to transform the pharma industry have been underway for a while now. In fact, reports suggest that the global health-related AI market is set to be worth $284bn by 2030.  Pharmaceutical development company Algorae (ASX: 1AI) is one of the companies at the forefront of this

    Read More
    Public
  • Powell suggest that rate cuts are getting closer, markets continue higher
    • Market Update

    Powell suggest that rate cuts are getting closer, markets continue higher

    The XJO is expected to rally on open this morning following a rebound overnight in the U.S. Their futures are flat this morning. Recently we have been leading the U.S. Yesterday we rebounded from key support at roughly 7,700, and roughly where the uptrend line comes in. The U.S overnight followed suit. GDP data came

    Read More
    Public
  • Carly Holdings’ EV Trial targets aspiring EV buyers
    • News

    Carly Holdings’ EV Trial targets aspiring EV buyers

    Most consumers love ‘try before you buy’ opportunities, especially when the goods or services involved are big ticket items laden with new technology not yet fully understood by the general population. Such test runs are effectively a way for potential purchasers to undertake some due diligence on a product before deciding to take the plunge

    Read More
    Public
  • Can cannabis cure insomnia? Avecho gets ethics approval to test in Phase 3 trials
    • News

    Can cannabis cure insomnia? Avecho gets ethics approval to test in Phase 3 trials

    For many, a bad night’s sleep can be chalked up to a late night out, stress and such. However, multiple nights of restless sleep could mean something more. Insomnia is among the two most common sleep disorders in Australia, with the second being obstructive sleep apnea. About 60% of Aussies display symptoms of insomnia. With

    Read More
    Public
  • Tourism Holding divests share in Camplify due to lack of return on funds
    • News

    Tourism Holding divests share in Camplify due to lack of return on funds

    On the heels of a mixed recreational vehicles (RVs) market, global tourism operator Tourism Holdings Limited (ASX: THL) has finalised the sale of its 14.14% stake in Camplify Holdings Limited (ASX: CHL), a peer-to-peer RV rental operator. The sale, based on a per-share price of $1.90, fetched approximately $19.2 million in gross proceeds for thl.

    Read More
    Public
  • Rent.com.au expands RentPay to include digital wallets to meet demand for flexible payment options
    • News

    Rent.com.au expands RentPay to include digital wallets to meet demand for flexible payment options

    With more than 500,000 migrants arriving in Australia annually, most on student and working visas quickly find that housing becomes their largest expense while trying to integrate into a new culture. It’s why so many get slugged by exorbitant foreign exchange and admin fees when trying to navigate Australia’s banking system, and also why Rent.com.au

    Read More
    Public
  • «
  • ‹
  • 108
  • 109
  • 110
  • 111
  • 112
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.